昊帆生物 (301393.SZ)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

利润表(单季度)(昊帆生物)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年第一季度2023年第四季度2023年第三季度2023年第二季度2023年第一季度2022年第二季度2022年第一季度
上市前/上市后 上市后上市后上市后上市前上市前上市前上市前
报表类型 合并报表合并报表合并报表合并报表合并报表合并报表合并报表
一、营业总收入(元) 91,229,728.7185,155,980.1493,536,390.4984,892,575.63125,210,000.82149,281,544.94121,083,971.40
 营业收入(元) 91,229,728.7185,155,980.1493,536,390.4984,892,575.63125,210,000.82149,281,544.94121,083,971.40
二、营业总成本(元) 61,494,588.6958,568,617.1975,921,192.7361,130,854.7682,947,104.04100,522,073.0481,662,451.99
 营业成本(元) 56,531,270.9055,927,665.4363,291,061.6548,208,376.0971,474,498.0888,850,625.6369,320,235.85
 研发费用(元) 10,389,895.998,366,907.968,748,336.916,693,708.234,665,960.487,980,039.244,432,561.52
 营业税金及附加(元) 600,805.24953,311.59575,604.58618,797.66386,836.30865,641.661,099,737.97
 销售费用(元) 2,182,431.612,490,272.024,495,932.643,247,975.521,719,086.102,935,556.301,966,806.03
 管理费用(元) 5,731,275.777,072,387.697,858,953.125,316,168.223,767,006.323,572,661.994,545,741.21
 财务费用(元) -13,941,090.82-16,241,927.50-9,048,696.17-2,954,170.96933,716.76-3,682,451.78297,369.41
  其中:利息费用(元) 16,356.3324,577.42-2,721.928,884.7214,530.5522,954.2322,949.75
  其中:利息收入(元) 12,439,672.8520,132,375.786,985,155.83236,610.03143,614.88222,673.2569,976.10
 资产减值损失(元) 634,404.65-3,564,287.05-73,062.28-266,079.39-630,234.08-357,568.74-317,715.70
 信用减值损失(元) -1,253,202.70196,289.57219,765.161,320,141.70-2,296,398.71-623,818.60-883,432.49
三、其他经营收益
 加:公允价值变动收益(元) 277,995.89-2,741,120.54-----
 加:投资收益(元) --0.03666,707.41670,684.93171,799.88-1,246,050.69387,665.75
 其他收益(元) 4,774,574.412,056,970.53699,316.47373,126.222,566,098.14554,387.26527,331.01
四、营业利润(元) 34,168,912.2722,535,085.9522,093,340.9525,859,594.3342,074,162.0147,086,421.1339,135,367.98
 加:营业外收入(元) 101,495.0115,857.132,250.44--675.8711,409.36
 减:营业外支出(元) 41,247.50105,470.45----80,435.17
五、利润总额(元) 34,229,159.7822,445,472.6322,095,546.3925,870,684.5042,074,162.0147,087,097.0039,066,342.17
 减:所得税费用(元) 4,400,320.042,371,621.961,933,297.143,421,031.855,786,160.055,604,208.455,968,259.46
六、净利润(元) 29,828,839.7420,073,850.6720,162,249.2522,449,652.6536,288,001.9641,482,888.5533,098,082.71
(一)按经营持续性分类
  持续经营净利润(元) 29,828,839.7420,073,850.6720,162,249.2522,449,652.6536,288,001.9641,482,888.5533,098,082.71
(二)按所有权归属分类
  归属于母公司股东的净利润(元) 29,828,839.7420,073,850.6720,162,249.2522,449,652.6536,288,001.9641,482,888.5533,098,082.71
 扣除非经常性损益后的净利润(元) 25,769,764.0321,434,174.4616,478,650.3721,553,023.4733,960,800.0042,070,200.0032,379,000.00
七、每股收益
 一、基本每股收益(元) 0.280.160.180.280.450.510.41
 二、稀释每股收益(元) 0.280.160.180.280.450.510.41
九、综合收益总额(元) 29,828,839.7420,073,850.6720,162,249.2522,449,652.6536,288,001.9641,482,888.5533,098,082.71
 归属于母公司所有者的综合收益总额(元) 29,828,839.7420,073,850.6720,162,249.2522,449,652.6536,288,001.9641,482,888.5533,098,082.71
公告日期 2024-04-262024-04-092023-10-252023-08-182023-06-202022-11-042023-06-20
审计意见(境内) 标准无保留意见标准无保留意见

前瞻产业研究院